New Business Development, AVEVE Biochem NV, Belgium
*Corresponding author: Kirsten De Keyser, DVM, PhD, AVEVE Biochem NV, Eugeen Meeusstraat 6, 2170 Merksem, Belgium, Tel: +3236410574/+32473632516; Email: firstname.lastname@example.org
Submission: October 13, 2017; Published: January 30, 2018
ISSN: 2576-9162Volume2 Issue4
The key to optimal animal production is a balanced gut. Performance pressure renders broilers vulnerable to infectious and/or non-infectious triggers. With the European withdrawal of antimicrobial growth promoters (AGP) in 2006, enteric broiler diseases became more prevalent in the EU. A common syndrome causing intestinal health aberrance is called ‘dysbiosis’ or ‘dysbacteriosis’ . This condition hampers a proper digestion thus compromises productivity, survival and well being whilst increasing time and cost of therapeutic treatment.